Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

Ítems similars

• In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
  per: Krause, Kevin M., et al.
  Publicat: (2008)
• Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
  per: Arhin, Francis F., et al.
  Publicat: (2009)
• In Vitro Activity of Linezolid against Key Gram-Positive Organisms Isolated in the United States: Results of the LEADER 2004 Surveillance Program
  per: Draghi, Deborah C., et al.
  Publicat: (2005)
• Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001
  per: Karlowsky, James A., et al.
  Publicat: (2003)
• In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
  per: Wenzel, Richard P., et al.
  Publicat: (2003)